Chronic Hepatitis B Infection and Liver Disease (HEPCARE)
HEPCARE is a community-based study situated in Jiangsu Province, China. It aims to investigate the progression of disease from diagnosis of hepatitis B virus (HBV) to end-stage liver disease, and explore the genetic and environmental risk factors for HBV. The study recruited participants from 2009 to 2023, enrolling individuals with a diagnosis of HBV or chronic hepatitis B virus. Approximately 7,000 participants were diagnosed through serosurveys conducted at baseline in 2009 and were included in the cohort. Since enrollment, the study has conducted 7 rounds of follow-ups, occurring every 1 to 2 years, with the most recent being in 2023.
Study design
Cohort - clinical, Cohort
Number of participants at first data collection
7,250 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Vaired (participants)
Participant sex
All
Representative sample at baseline?
The population of individuals living with HBV in Jiangsu, China.
Sample features
Country
Year of first data collection
2009
Primary Institutions
Nanjing Medical University (南京医科大学, NJMU)
Links
No website available
Profile paper DOI
Funders
Jiangsu Provincial Key Discipline of Epidemiology
National Major Science and Technology
National Natural Science Foundation of China (国家自然科学基金委员会, NSFC)
Scientific research project of Jiangsu Provincial Health Commission
Ongoing?
Yes
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Census data
- Healthcare data
- Mortality data
Engagement
Keywords
